Issue link: https://beckershealthcare.uberflip.com/i/821337
64 CIO / HEALTH IT ligence based cognitive agents to engage with consumers via voice commands which will advance over time to per- form more complex tasks such as ad- mitting patients to hospitals; and • Cognitive automation — machine intelligence baked into devices and processes that develops deep do- main-specific expertise then auto- mates related tasks, freeing up work- ers to focus on higher value activities. We expect the growth to continue, with spending on machine intelligence expected to rise to $31.3 billion by 2019 [according to the International Data Corporation]." Lisa Suennen. Managing Director at GE Ventures (Menlo Park, Calif.): "AI of- fers the opportunity to free physicians and oth- er clinicians from tedious work analyzing data, giving them time to apply their knowledge in a more focused, informed way. We think AI allows clinicians to work at the highest level of their ability by making them far more in- formed and effective patient advocates." n 23andMe to Offer At-Home Genetic Tests for 10 Diseases By Mackenzie Bean T he Food and Drug Adminis- tration on April 6 approved 23andMe's home DNA tests consumers can use to assess their genetic risk for various diseases, re- ports The New York Times. The DNA tests identify genetic risks for 10 diseases, including Parkin- son's, Alzheimer's and rare blood diseases. The Ancestry and Health test — just one of several offerings — costs $199. To conduct the test, customers send a saliva sample to 23andME, which then extracts the DNA from saliva cells and tests it for genetic markers. Six to eight weeks later, the compa- ny emails customers, alerting them their test results are available to ac- cess online. The approval marks the first time the FDA has allowed a company to market genetic tests directly to con- sumers. Traditionally, patients need to visit a medical professional — and sometimes a genetic counselor — who order the test and later deliver the results, according to the report. "Consumers can now have direct access to certain genetic risk infor- mation," Jeffrey Shuren, MD, director of the FDA's Center for Devices and Radiological Health, said in a state- ment. "But it is important that peo- ple understand that genetic risk is just one piece of the bigger puzzle. It does not mean they will or won't ultimately develop a disease." n Cleveland Clinic Creates Venture Arm to Maximize Results of Spinoff Companies By Ayla Ellison C leveland Clinic has created a new entity to collaborate with Cleveland Clinic Innovations to help build its pipeline of startups into successful, sustainable companies. Cleveland Clinic Innovations helps turn medical breakthrough inventions into products and companies. Since it was created in 2000, CCI has issued over 850 patents and executed more than 500 licenses on medical devices and techniques. The new department within CCI, Cleveland Clinic Ventures, will help raise funds to get innovative ideas to market and to maximize the performance of spinoff companies. Brian Donley, MD, Cleveland Clinic's chief of staff, told Becker's CCV will as- sist the spinoff companies with fund- ing strategies, business model devel- opment and technology road maps. "This new structure will position us to have an even more robust, stream- lined commercialization impact and successfully fulfill our potential as a world-class destination for healthcare commercialization," says Dr. Donley. "Cleveland Clinic Innovations and Cleveland Clinic Ventures work to- gether seamlessly, sharing expertise, with a relentless focus on advancing technologies to improve patient care for Cleveland Clinic patients, and oth- er patients locally, nationally and inter- nationally." Cleveland Clinic recently appoint- ed new leaders for both entities. Peter O'Neill was named executive director of Cleveland Clinic Innova- tions and Jack Miner was appoint- ed managing director of Cleveland Clinic Ventures. n No. 1 Cost of Ransomware Attack is Downtime, Survey Finds By Jessica Kim Cohen S ecurity professionals share four main concerns about ransomware, accord- ing to an Imperva report. Imperva surveyed 170 security profession- als to gauge their attitudes and experienc- es surrounding ransomware. In total, 30 percent of the respondents' companies had been infected by ransomware. Here are the top four concerns security pro- fessionals reported. 1. Cost of downtime, due to lack of access to systems: 59 percent 2. Bad publicity and reduced customer sat- isfaction: 14 percent 3. Lost sales: 12 percent 4. Paying the ransom: 11 percent However, regardless of downtime concerns, 79 percent of respondents agreed the smart- est move is to not pay the ransom. n